MedCap AB (publ)
STO:MCAP

Watchlist Manager

MedCap AB (publ)

STO:MCAP

Watchlist

Dividends

Discount Rate

Price: 543 SEK -4.57%

Market Cap: 8B SEK

Have any thoughts about
MedCap AB (publ)?

Write Note

Write Note Create Alert Ask AI

Add Note Why Create Notes?

Capture your thoughts

Note Buy Sell Hold Pass

US	Johnson & Johnson NYSE:JNJ	Pharmaceuticals
US	Berkshire Hathaway Inc NYSE:BRK.A	Financial Services
US	Bank of America Corp NYSE:BAC	Banking
US	Mastercard Inc NYSE:MA	Technology
US	UnitedHealth Group Inc NYSE:UNH	Health Care
US	Exxon Mobil Corp NYSE:XOM	Energy
US	Pfizer Inc NYSE:PFE	Pharmaceuticals
US	Palantir Technologies Inc NYSE:PLTR	Technology
US	Nike Inc NYSE:NKE	Textiles, Apparel & Luxury Goods
US	Visa Inc NYSE:V	Technology
CN	Alibaba Group Holding Ltd NYSE:BABA	Retail
US	3M Co NYSE:MMM	Industrial Conglomerates
US	JPMorgan Chase & Co NYSE:JPM	Banking
US	Coca-Cola Co NYSE:KO	Beverages
US	Walmart Inc NYSE:WMT	Retail
US	Verizon Communications Inc NYSE:VZ	Telecommunication

Add Price Alert

Price Target:

Last Price: 543 SEK

We'll email you a reminder when the closing price reaches USD.

If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Peter Lynch

Track and Analyze Performance

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.

Continuous Learning and Adaptation

Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.

Boost Decision Confidence

With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.

Why create notes?

Back

Delete Note

Do you really want to delete this note?
This action cannot be undone.

Remove price alert for reaching

Delete

Cancel

MCAP Alert

MedCap AB (publ)

543

-26 (-4.57%)

52 Week Range	300.5 609
Price Target

We'll email you a reminder when the closing price reaches SEK.

Save Alert

Choose the stock you wish to monitor with a price alert.

	Johnson & Johnson NYSE:JNJ	US
	Berkshire Hathaway Inc NYSE:BRK.A	US
	Bank of America Corp NYSE:BAC	US
	Mastercard Inc NYSE:MA	US
	UnitedHealth Group Inc NYSE:UNH	US
	Exxon Mobil Corp NYSE:XOM	US
	Pfizer Inc NYSE:PFE	US
	Palantir Technologies Inc NYSE:PLTR	US
	Nike Inc NYSE:NKE	US
	Visa Inc NYSE:V	US
	Alibaba Group Holding Ltd NYSE:BABA	CN
	3M Co NYSE:MMM	US
	JPMorgan Chase & Co NYSE:JPM	US
	Coca-Cola Co NYSE:KO	US
	Walmart Inc NYSE:WMT	US
	Verizon Communications Inc NYSE:VZ	US

Delete Alert

This alert will be permanently deleted.

Remove note

Delete

Cancel

Ask me anything about

MedCap AB (publ)

What unique competitive advantages
does MedCap AB (publ) hold over its rivals?

What risks and challenges
does MedCap AB (publ) face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Provide an overview of the primary business activities
of MedCap AB (publ).

What unique competitive advantages
does MedCap AB (publ) hold over its rivals?

What risks and challenges
does MedCap AB (publ) face in the near future?

Has there been any significant insider trading activity
in MedCap AB (publ) recently?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for MedCap AB (publ).

Provide P/S
for MedCap AB (publ).

Provide P/E
for MedCap AB (publ).

Provide P/OCF
for MedCap AB (publ).

Provide P/FCFE
for MedCap AB (publ).

Provide P/B
for MedCap AB (publ).

Provide EV/S
for MedCap AB (publ).

Provide EV/GP
for MedCap AB (publ).

Provide EV/EBITDA
for MedCap AB (publ).

Provide EV/EBIT
for MedCap AB (publ).

Provide EV/OCF
for MedCap AB (publ).

Provide EV/FCFF
for MedCap AB (publ).

Provide EV/IC
for MedCap AB (publ).

Show me price targets
for MedCap AB (publ) made by professional analysts.

What are the Revenue projections
for MedCap AB (publ)?

How accurate were the past Revenue estimates
for MedCap AB (publ)?

What are the Net Income projections
for MedCap AB (publ)?

How accurate were the past Net Income estimates
for MedCap AB (publ)?

What are the EPS projections
for MedCap AB (publ)?

How accurate were the past EPS estimates
for MedCap AB (publ)?

What are the EBIT projections
for MedCap AB (publ)?

How accurate were the past EBIT estimates
for MedCap AB (publ)?

Compare the revenue forecasts
for MedCap AB (publ) with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of MedCap AB (publ) and its key competitors using the latest financial data.

Compare historical revenue growth rates
of MedCap AB (publ) against its competitors.

Analyze the profit margins
(gross, operating, and net) of MedCap AB (publ) compared to its peers.

Compare the P/E ratios
of MedCap AB (publ) against its peers.

Discuss the investment returns and shareholder value creation
comparing MedCap AB (publ) with its peers.

Analyze the financial leverage
of MedCap AB (publ) compared to its main competitors.

Show all profitability ratios
for MedCap AB (publ).

Provide ROE
for MedCap AB (publ).

Provide ROA
for MedCap AB (publ).

Provide ROIC
for MedCap AB (publ).

Provide ROCE
for MedCap AB (publ).

Provide Gross Margin
for MedCap AB (publ).

Provide Operating Margin
for MedCap AB (publ).

Provide Net Margin
for MedCap AB (publ).

Provide FCF Margin
for MedCap AB (publ).

Show all solvency ratios
for MedCap AB (publ).

Provide D/E Ratio
for MedCap AB (publ).

Provide D/A Ratio
for MedCap AB (publ).

Provide Interest Coverage Ratio
for MedCap AB (publ).

Provide Altman Z-Score Ratio
for MedCap AB (publ).

Provide Quick Ratio
for MedCap AB (publ).

Provide Current Ratio
for MedCap AB (publ).

Provide Cash Ratio
for MedCap AB (publ).

What is the historical Revenue growth
over the last 5 years for MedCap AB (publ)?

What is the historical Net Income growth
over the last 5 years for MedCap AB (publ)?

What is the current Free Cash Flow
of MedCap AB (publ)?

Discuss the annual earnings per share (EPS)
trend over the past five years for MedCap AB (publ).

EV/EBITDA
Enterprise Value to EBITDA

19.8

Current

14.4

Median

18.6

Industry

Higher than median

Higher than industry value

Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.

EV/EBITDA

19.8

Enterprise Value

8B SEK

EBITDA

405.5m SEK

All Countries

Forward Multiples

			Market Cap	EV/EBITDA
SE		MedCap AB (publ) STO:MCAP	8B SEK	19.8
US	P	PerkinElmer Inc LSE:0KHE	1.3T USD	1 567.3
US		Thermo Fisher Scientific Inc NYSE:TMO	196.2B USD	20.8
US		Danaher Corp NYSE:DHR	170.9B USD	27.5
KR		Samsung Biologics Co Ltd KRX:207940	67.6T KRW	34.8
CH		Lonza Group AG SIX:LONN	38.5B CHF	45.5
US		Agilent Technologies Inc NYSE:A	38.6B USD	21.4
US		IQVIA Holdings Inc NYSE:IQV	36.5B USD	14.3
US		Mettler-Toledo International Inc NYSE:MTD	26.7B USD	24.1
US		West Pharmaceutical Services Inc NYSE:WST	23.2B USD	31.1
US		Waters Corp NYSE:WAT	23B USD	23.6

				EBITDA Growth
SE		MedCap AB (publ) STO:MCAP	Average EV/EBITDA: 166.4 19.8	N/A
US	P	PerkinElmer Inc LSE:0KHE	1 567.3	23%
US		Thermo Fisher Scientific Inc NYSE:TMO	20.8	19%
US		Danaher Corp NYSE:DHR	27.5	22%
KR		Samsung Biologics Co Ltd KRX:207940	34.8	57%
CH		Lonza Group AG SIX:LONN	45.5	36%
US		Agilent Technologies Inc NYSE:A	21.4	31%
US		IQVIA Holdings Inc NYSE:IQV	14.3	32%
US		Mettler-Toledo International Inc NYSE:MTD	24.1	16%
US		West Pharmaceutical Services Inc NYSE:WST	31.1	16%
US		Waters Corp NYSE:WAT	23.6	19%

EV/EBITDA Forward Multiples

Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward

EV/EBITDA

N/A

2-Years Forward

EV/EBITDA

N/A

3-Years Forward

EV/EBITDA

N/A

MedCap AB (publ)
STO:MCAP

EV/EBITDA
Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

MedCap AB (publ) STO:MCAP

EV/EBITDA Enterprise Value to EBITDA

EV/EBITDA Forward Multiples

See Also

Company

Help

Tools

Stocks

MedCap AB (publ)
STO:MCAP

EV/EBITDA
Enterprise Value to EBITDA